Antimicrobial resistance (AMR) is a growing public health challenge that is expected to
disproportionately burden lower-and middle-income countries (LMICs) in the coming …

Background: Antimicrobial resistance is a serious public-health problem throughout the
world. Escherichia coli, the most common Gram-negative microorganism, has developed …

Klebsiella oxytoca is rising as a significant opportunistic pathogen causing nosocomial
infections in neonates as well as adults. This pathogen's prevalence varies from 2 to 24 …

The global prevalence of colistin-resistant Klebsiella pneumoniae (ColRkp) facilitated by
chromosomal and plasmid-mediated Ara4N or PEtN-remodeled LPS alterations has steadily …

Objectives The continuing rise in infections caused by multidrug-resistant (MDR) bacteria is
one of the most serious public-health issues in society today. Colistin is a last-resort …

Phage therapy is one of the promising alternatives to combat the increasing problem of
antibiotic resistance. Lyophilization is used for the preparation of pharmaceutical products to …

Carbapenem-resistant Enterobacteriaceae infections have spread globally, leaving
polymyxins, including colistin, as 'last-resort treatments'. Emerging colistin resistance raises …

ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

Background Phage therapy is the therapeutic use of bacteriophages to treat highly drug
resistant bacterial infections. The current surge in bacteriophage therapy is motivated mainly …

Introduction: Increasing occurrence of infections caused by multidrug-resistant Gram-
negative bacteria resulted in colistin being the last agent for treatment. Apart from plasmid …